tiprankstipranks
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market
XRTX
XORTX Therapeutics Inc
RESEARCH TOOLSreports
Want to see XRTX full AI Analyst Report?

XORTX Therapeutics Inc (XRTX) Financial Statements

83 Followers

XORTX Therapeutics Inc Financial Overview

XORTX Therapeutics Inc's market cap is currently $3.78M. The company's EPS TTM is $-16; its P/E ratio is -1.53; XORTX Therapeutics Inc is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -156.66KC$ -160.66K-C$ -75.27KC$ -17.88K
Operating IncomeC$ -4.55MC$ -5.64M-C$ -12.43M-
EBITDAC$ -4.39MC$ -4.38M-C$ -9.41M-
Net IncomeC$ -3.71MC$ -4.54M--C$ -1.65M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.19MC$ 3.56MC$ 3.45MC$ 10.43MC$ 14.79M
Total AssetsC$ 3.68MC$ 5.89MC$ 5.47MC$ 12.37MC$ 17.38M
Total DebtC$ 51.11KC$ 55.78KC$ 11.51KC$ 77.60KC$ 0.00
Net DebtC$ -1.13MC$ -3.50MC$ -3.44MC$ -10.36MC$ -14.87M
Total LiabilitiesC$ 821.18KC$ 1.09MC$ 825.94KC$ 5.38MC$ 4.18M
Stockholders' EquityC$ 2.86MC$ 4.80MC$ 4.64MC$ 7.00MC$ 13.20M
Cash Flow
Free Cash FlowC$ -3.87MC$ -5.04MC$ -6.63MC$ -9.01MC$ -4.83M
Operating Cash FlowC$ -3.87MC$ -5.04MC$ -6.58MC$ -8.96MC$ -4.80M
Investing Cash FlowC$ -412.13KC$ -53.32KC$ -46.36KC$ -45.70KC$ -31.81K
Financing Cash FlowC$ 1.99MC$ 3.81MC$ -487.30KC$ 4.71MC$ 19.37M
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

Income Statement >

XORTX Therapeutics Inc Debt to Assets

Balance Sheet >

XORTX Therapeutics Inc Cash Flow

Cash Flow >

XORTX Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >